Physician

Jeremy Scott Norwood, M.D.

According to 2025 Medicare claims, Jeremy Norwood, M.D. (NPI: 1801010921) practices urology in the Daphne-Fairhope-Foley, AL market, with the plurality of this provider's patient population coming from Baldwin, AL. This provider's primary affiliated billing organization is UROLOGY ASSOCIATES OF MOBILE, P.A. (NPI: 1194828368; TIN: 63-0576885) and primary practice location at 36535-2264.

Norwood's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 608 traditional Medicare patients, billed 42,613 HCPCS/CPT codes, and received $402,188 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,873 prescription claims across 603 beneficiaries totaling $1,107,645 in drug costs, led by Erleada (Apalutamide). DME data shows 25 claims. Open Payments data shows 73 records totaling $1,569. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $387,032 and ending at $402,188. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $149,010 and ending at $1,107,645. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	555	9,786	$387,032
2016	554	10,268	$357,778
2017	654	10,494	$270,296
2018	907	13,004	$390,709
2019	894	14,838	$317,082
2020	854	19,811	$277,229
2021	665	7,639	$174,270
2022	392	18,783	$255,687
2023	475	35,603	$324,728
2024	608	42,613	$402,188

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	183	733	$149,010
2016	184	756	$86,144
2017	239	969	$252,425
2018	372	1,490	$704,144
2019	394	1,731	$582,304
2020	387	1,498	$243,896
2021	391	1,229	$91,811
2022	336	779	$81,657
2023	468	1,199	$442,148
2024	603	1,873	$1,107,645

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	58	$13,618
2016	N/R	58	$12,922
2017	N/R	34	$15,900
2018	N/R	47	$21,594
2019	N/R	56	$24,186
2020	N/R	46	$22,211
2021	11	41	$18,365
2022	N/R	41	$5,971
2023	N/R	25	$5,060
2024	N/R	25	$6,003

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	350	721	$117
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	252	401	$85
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	448	864	$11
36415	Insertion of needle into vein for collection of blood sample	161	240	$9
81003	Automated urinalysis test	516	1,167	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Erleada	Apalutamide	41	1,230	$581,551
Orgovyx	Relugolix	88	2,640	$229,097
Gemtesa	Vibegron	66	5,060	$77,664
Myrbetriq	Mirabegron	57	3,692	$54,860
Tamsulosin Hcl	Tamsulosin Hcl	657	56,882	$8,270

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	25	$6,003

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	73	$1,569	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jeremy Scott Norwood, M.D.?

Tedicare shows public-source Medicare data for Jeremy Scott Norwood, M.D. (NPI 1801010921), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jeremy Scott Norwood, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jeremy Scott Norwood, M.D.?

Jeremy Scott Norwood, M.D. is linked to UROLOGY ASSOCIATES OF MOBILE, P.A. (billing NPI 1194828368) in the available physician profile data.

Does Jeremy Scott Norwood, M.D. have Open Payments data?

Jeremy Scott Norwood, M.D. has 73 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.